Pharmacologie des corticostéroïdes inhalés : nouvelles données et implications thérapeutiques = Inhaled glucocorticoid pharmacologyEDSBÄCKER, S.Revue de pneumologie clinique (Paris). 1998, Vol 54, pp S14-S16, issn 0761-8417, SUP1Conference Paper

Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacerTHORSSON, L; EDSBÄCKER, S.The European respiratory journal. 1998, Vol 12, Num 6, pp 1340-1345, issn 0903-1936Article

Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's diseaseLUNDIN, P; NABER, T; NILSSON, M et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 1, pp 45-51, issn 0269-2813Article

Nasal bioavailability and systemic effects of the glucocortocid budesonide in manEDSBACKER, S; ANDERSSON, K.-E; RYRFELDT, A et al.European journal of clinical pharmacology. 1985, Vol 29, Num 4, pp 477-481, issn 0031-6970Article

A cortisol suppression dose-response comparison of budesonide in controlled ileal release capsules with prednisoloneEDSBÄCKER, S; NILSSON, M; LARSSON, P et al.Alimentary pharmacology & therapeutics. 1999, Vol 13, Num 2, pp 219-224, issn 0269-2813Article

The use of on-line liquid chromatography/mass spectrometry and stable isotope techniques for the identification of budesonide metabolitesLINDBERG, C; PAULSON, J; EDSBACKER, S et al.Biomedical & environmental mass spectrometry. 1987, Vol 14, Num 10, pp 535-541, issn 0887-6134Article

Kinetics of the epimeric glucocorticoid budesonideRYRFELDT, A; EDSBACKER, S; PAUWELS, R et al.Clinical pharmacology and therapeutics. 1984, Vol 35, Num 4, pp 525-530, issn 0009-9236Article

Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisolSEIDEGARD, J; SIMONSSON, M; EDSBÄCKER, S et al.Clinical pharmacology and therapeutics. 2000, Vol 67, Num 4, pp 373-381, issn 0009-9236Article

Systemic availability of budesonide after nasal administration of three different formulations : pressurized aerosol, aqueous pump spray, and powderTHORSSON, L; BORGA, O; EDSBÄCKER, S et al.British journal of clinical pharmacology. 1999, Vol 47, Num 6, pp 619-624, issn 0306-5251Article

Rectal pharmacokinetics of budesonideDAHLSTRÖM, K; EDSBÄCKER, S; KÄLLEN, A et al.European journal of clinical pharmacology. 1996, Vol 49, Num 4, pp 293-298, issn 0031-6970Article

Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's diseaseLUNDIN, P. D. P; EDSBÄCKER, S; BERGSTRAND, M et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 1, pp 85-92, issn 0269-2813, 8 p.Article

Relationship between lung tissue and blood plasma concentrations of inhaled budesonideVAN DEN BOSCH, J. M. M; WESTERMANN, C. J. J; AUMANN, J et al.Biopharmaceutics & drug disposition. 1993, Vol 14, Num 5, pp 455-459, issn 0142-2782Article

A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsulesEDSBÄCKER, S; BENGTSSON, B; LARSSON, P et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 4, pp 525-536, issn 0269-2813, 12 p.Article

Dose-proportional pharmacokinetics of budesonide inhaled via turbuhaler®KAISER, H; AARONSON, D; DOCKHORN, R et al.British journal of clinical pharmacology. 1999, Vol 48, Num 3, pp 309-316, issn 0306-5251Article

Liver metabolism of budesonide in rat, mouse, and man: comparative aspectsEDSBACKER, S; ANDERSSON, P; LINDBERG, C et al.Drug metabolism and disposition. 1987, Vol 15, Num 3, pp 403-411, issn 0090-9556Article